Bessemer Group Inc Charles River Laboratories International, Inc. Transaction History

Bessemer Group Inc

  • $61.3 Billion
  • Q4 2024

A detailed history of Bessemer Group Inc transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Bessemer Group Inc holds 23,473 shares of CRL stock, worth $2.5 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
23,473
Previous 23,476 0.01%
Holding current value
$2.5 Million
Previous $4.62 Million 6.29%
% of portfolio
0.01%
Previous 0.01%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025
SELL
$178.58 - $220.69 $535 - $662
-3 Reduced 0.01%
23,473 $4.33 Million
Q3 2024

Nov 12, 2024
BUY
$187.96 - $245.29 $2.79 Million - $3.63 Million
14,818 Added 171.15%
23,476 $4.62 Million
Q2 2024

Aug 13, 2024
BUY
$206.39 - $268.73 $1,857 - $2,418
9 Added 0.1%
8,658 $1.79 Million
Q1 2024

May 13, 2024
BUY
$203.52 - $273.43 $1.44 Million - $1.94 Million
7,095 Added 456.56%
8,649 $2.34 Million
Q4 2023

Feb 09, 2024
SELL
$164.52 - $238.84 $13,161 - $19,107
-80 Reduced 4.9%
1,554 $367,000
Q3 2023

Nov 13, 2023
SELL
$194.44 - $217.61 $6,416 - $7,181
-33 Reduced 1.98%
1,634 $320,000
Q2 2023

Aug 10, 2023
BUY
$183.71 - $210.25 $74,218 - $84,941
404 Added 31.99%
1,667 $351,000
Q1 2023

May 10, 2023
SELL
$191.89 - $259.92 $11,705 - $15,855
-61 Reduced 4.61%
1,263 $255,000
Q4 2022

Feb 13, 2023
BUY
$197.11 - $250.07 $118,463 - $150,292
601 Added 83.13%
1,324 $289,000
Q3 2022

Nov 09, 2022
SELL
$182.44 - $250.54 $45,062 - $61,883
-247 Reduced 25.46%
723 $142,000
Q2 2022

Aug 10, 2022
SELL
$204.13 - $302.4 $155,138 - $229,823
-760 Reduced 43.93%
970 $208,000
Q1 2022

May 12, 2022
SELL
$255.51 - $362.11 $66,432 - $94,148
-260 Reduced 13.07%
1,730 $491,000
Q4 2021

Jan 27, 2022
SELL
$351.38 - $448.68 $93,818 - $119,797
-267 Reduced 11.83%
1,990 $749,000
Q3 2021

Nov 12, 2021
BUY
$372.64 - $458.3 $2,981 - $3,666
8 Added 0.36%
2,257 $931,000
Q2 2021

Aug 06, 2021
BUY
$294.17 - $371.65 $252,397 - $318,875
858 Added 61.68%
2,249 $832,000
Q1 2021

May 13, 2021
SELL
$249.67 - $299.48 $111,103 - $133,268
-445 Reduced 24.24%
1,391 $403,000
Q4 2020

Feb 09, 2021
BUY
$222.0 - $252.62 $15,096 - $17,178
68 Added 3.85%
1,836 $458,000
Q3 2020

Nov 12, 2020
SELL
$175.56 - $226.45 $18,784 - $24,230
-107 Reduced 5.71%
1,768 $400,000
Q1 2020

Apr 30, 2020
BUY
$98.9 - $178.34 $43,516 - $78,469
440 Added 30.66%
1,875 $237,000
Q2 2019

Jul 19, 2019
SELL
$123.4 - $148.55 $10,982 - $13,220
-89 Reduced 5.84%
1,435 $204,000
Q1 2019

May 13, 2019
SELL
$104.82 - $146.73 $16,247 - $22,743
-155 Reduced 9.23%
1,524 $221,000
Q4 2018

Feb 12, 2019
SELL
$105.09 - $137.23 $8,512 - $11,115
-81 Reduced 4.6%
1,679 $190,000
Q3 2017

Nov 03, 2017
BUY
$96.72 - $109.26 $170,227 - $192,297
1,760
1,760 $190,000

Others Institutions Holding CRL

# of Institutions
704
Shares Held
50.8M
Call Options Held
122K
Put Options Held
239K
View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

CRL Quotes by TradingView
  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $5.42B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Bessemer Group Inc Portfolio

Follow Bessemer Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bessemer Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bessemer Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email